Insulin aspart, recombinant Subcutaneous and Ixabepilone Intravenous
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Ixabepilone Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: ixabepilone
Brand name: Ixempra
Synonyms: Ixabepilone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Ixazomib
- Insulin aspart, recombinant Subcutaneous-Ixazomib Citrate
- Insulin aspart, recombinant Subcutaneous-Ixekizumab
- Insulin aspart, recombinant Subcutaneous-Ixekizumab Auto-Injectors
- Insulin aspart, recombinant Subcutaneous-Ixekizumab Prefilled Syringes
- Insulin aspart, recombinant Subcutaneous-Ixekizumab Subcutaneous
- Ixabepilone Intravenous-Insulin degludec
- Ixabepilone Intravenous-Insulin Degludec (U-100) Prefilled Pens
- Ixabepilone Intravenous-Insulin Degludec (U-100) Vials
- Ixabepilone Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Ixabepilone Intravenous-Insulin degludec and liraglutide
- Ixabepilone Intravenous-Insulin degludec and liraglutide Subcutaneous